Bharat Biotech, Alopexx Inc of US to co-develop, commercialise anti-microbial vax AV0328
HYDERABAD:Bharat Biotech has entered into a collaboration with US-based clinical stage biotech player Alopexx Inc for the co-development and commercialization of the latter’s proprietary broad-spectrum anti-microbial vaccine, AV0328, in India and other low income and lower middle-income countries.As part of the collaboration, the companies will co-develop and commercialize AV0328, a synthetic vaccine targeting poly N-acetyl…